Why investors injected $62 million into a Peninsula biotech targeting a deadly lung disease

Pliant Therapeutics expects to have 50 employees by the end of the year and is recruiting for its first clinical trial.

Source: bizjournals.com Health Care:Biotechnology headlines - July 16, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news